- Home
- OSUR vs EOD Comparison
OSUR vs EOD Comparison
Compare OSUR & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- EOD
- Stock Information
- Founded
- OSUR 2000
- EOD 2007
- Country
- OSUR United States
- EOD United States
- Employees
- OSUR N/A
- EOD N/A
- Industry
- OSUR Medical/Dental Instruments
- EOD Investment Managers
- Sector
- OSUR Health Care
- EOD Finance
- Exchange
- OSUR Nasdaq
- EOD Nasdaq
- Market Cap
- OSUR 223.0M
- EOD 213.8M
- IPO Year
- OSUR 1986
- EOD N/A
- Fundamental
- Price
- OSUR $2.99
- EOD $4.95
- Analyst Decision
- OSUR Hold
- EOD
- Analyst Count
- OSUR 2
- EOD 0
- Target Price
- OSUR $5.50
- EOD N/A
- AVG Volume (30 Days)
- OSUR 624.9K
- EOD 118.1K
- Earning Date
- OSUR 05-07-2025
- EOD 01-01-0001
- Dividend Yield
- OSUR N/A
- EOD 9.28%
- EPS Growth
- OSUR N/A
- EOD N/A
- EPS
- OSUR N/A
- EOD N/A
- Revenue
- OSUR $185,827,000.00
- EOD N/A
- Revenue This Year
- OSUR N/A
- EOD N/A
- Revenue Next Year
- OSUR $7.55
- EOD N/A
- P/E Ratio
- OSUR N/A
- EOD N/A
- Revenue Growth
- OSUR N/A
- EOD N/A
- 52 Week Low
- OSUR $2.69
- EOD $3.73
- 52 Week High
- OSUR $5.59
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- OSUR 43.10
- EOD 55.51
- Support Level
- OSUR $2.84
- EOD $4.59
- Resistance Level
- OSUR $3.10
- EOD $4.80
- Average True Range (ATR)
- OSUR 0.15
- EOD 0.16
- MACD
- OSUR 0.02
- EOD 0.04
- Stochastic Oscillator
- OSUR 37.50
- EOD 93.42
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.